Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries

Circulation Research

Volumn 82, Issue 12, 1998, Pages 1306-1311

  Hamilton, Justin R ^b   Nguyen, Paul B ^b   Cocks, Thomas M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NONE

Author keywords

Endothelium dependent relaxation; Human coronary artery; Protease activated receptor; Thrombin; Trypsin

Indexed keywords

PROTEINASE;

ARTICLE; CATALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0032577955     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.12.1306     Document Type: Article

References (36)

1. Liu L-W, Vu T-KH, Esmon CT, Coughlin SR. The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. J Biol Chem. 1991;266:16977-16980.
2. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057-1068.
3. Coughlin SR. Protease-activated receptors start a family. Proc Natl Acad Sci USA. 1994;91:9200-9202.
4. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA. 1994;91:9208-9212.
5. Böhm SK, Kong W, Brömme D, Smeekens SP, Anderson DC, Connolly A, Kahn M, Nelken NA, Coughlin SR, Payan DG, Bunnett NW. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J. 1996;314:1009-1016.
6. Blackhart BD, Emilsson K, Nguyen D, Teng W, Martelli AJ, Nystedt S, Sundelin J, Scarborough RM. Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem. 1996;271:16466-16471.
7. Ishihara H. Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 1997;386:502-506.
8. Scarborough RM, Naughton M-A, Teng W, Hung DT, Rose J, Vu T-KH, Wheaton VI, Turek CW, Coughlin SR. Tethered ligand agonist peptides: structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J Biol Chem. 1992;267:13146-13149.
9. Hollenberg MD, Yang S-G, Laniyonu AA, Saifeddine M, Moore GJ. Action of the thrombin receptor polypeptide in gastric smooth muscle: identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity. Mol Pharmacol. 1992;42:186-191.
10. Saifeddine M, Al-Ani B, Cheng C-H, Wang L, Hollenberg MD. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br J Pharmacol. 1996;118:521-530.
11. Hwa JJ, Ghibaudi L, Williams P, Chintala M, Zhang R, Chatterjee M, Sybertz E. Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells. Circ Res. 1996;78:581-588.
12. Tesfamariam B, Allen GT, Normandin D, Antonaccio MJ. Involvement of the "tethered ligand" receptor in thrombin-induced endothelium-mediated relaxations. Am J Physiol. 1993;265:H1744-H1749.
13. Nelken NA, Soifer SJ, O'Keefe J, Vu T-K, Charo IF, Coughlin SR. Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest. 1992;90:1614-1621.
14. Lüscher TF, Diederich D, Siebenmann R, Lehmann K, Stulz P, von Segesser L, Yang Z, Turina M, Grädel E, Weber E, Bühler FR. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med. 1988;319:462-467.
15. 2-macroglobulin, and thrombin in human basilar arteries: relevance to cerebral vasospasm. J Cereb Blood Flow Metab. 1987;7:68-73.
16. Hatake K, Kakishita E, Wakabayashi I, Sakiyama N, Hishida S. Effect of ageing on endothelium-dependent vascular relaxation of isolated human basilar artery to thrombin and bradykinin. Stroke. 1990;21:1039-1043.
17. Ku DD, Winn MJ, Grigsby T, Caufield JB. Human coronary vascular smooth muscle and endothelium-dependent responses after storage at -75°C. Cryobiology. 1992;29:199-209.
18. 2+ mobilisation in human T cell lines through interaction with different protease-activated receptors. FASEB J. 1996;10:309-316.
19. Ngaiza JR, Jaffe EA. A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates prostacyclin production in human endothelial cells. Biochem Biophys Res Commun. 1991;179:1656-1661.
20. Kruse H-J, Mayerhofer C, Siess W, Weber PC. Thrombin receptor-activating peptide sensitizes the human endothelial thrombin receptor. Am J Physiol. 1995;268:C36-C44.
21. 2+ channels. Br J Pharmacol. 1996;117:1035-1040.
22. Stork AP, Cocks TM. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor. Br J Pharmacol. 1994;113:1099-1104.
23. Muramatsu I, Laniyonu A, Moore GJ, Hollenberg MD. Vascular actions of thrombin receptor peptide. Can J Physiol Pharmacol. 1992;70: 996-1003.
24. Hollenberg MD, Saifeddine M, Al-Ani B. Proteinase-activated receptor-2 in rat aorta: structural requirements for agonist activity of receptor-activating peptides. Mol Pharmacol. 1996;49:229-233.
25. Tesfamariam B. Distinct receptors and signaling pathways in a thrombin-and thrombin receptor peptide-induced vascular contractions. Circ Res. 1994;74:930-936.
26. Kemp BK, Cocks TM. Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries. Br J Pharmacol. 1997;120:757-762.
27. Chester AH, O'Neil GS, Tadjkarimi S, Palmer RMJ, Moncada S, Yacoub MH. The role of nitric oxide in mediating endothelium dependent relaxations in the human epicardial coronary artery. Int J Cardiol. 1990;29: 305-309.
28. White RP, Shimazaki Y, Robertson JT. Comparison of responses elicited by α-thrombin in isolated canine basilar, coronary, mesenteric and renal arteries. Blood Vessels. 1984;21:12-22.
29. Glusa E, Markwardt F. Studies on thrombin-induced endothelium-dependent vascular effects. Biomed Biochim Acta. 1988;47:623-630.
30. Brass LF, Manning DR, Williams AG, Woolkalis MJ, Poncz M. Receptor and G protein-mediated responses to thrombin in HEL cells. J Biol Chem. 1991;266:958-965.
31. Nystedt S, Larsson A-K, Åberg H, Sundelin J. The mouse proteinase-activated receptor-2 cDNA and gene. J Biol Chem. 1995;270:5950-5955.
32. Vassallo RR Jr. Kieber-Emmons T, Cichowski K, Brass LF. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J Biol Chem. 1992;267:6081-6085.
33. Hoxie JA, Ahuja M, Belmonte E, Pizarro S, Parton R, Brass LF. Internalization and recycling of activated thrombin receptors. J Biol Chem. 1993;268:13756-13763.
34. Hein L, Ishii K, Coughlin SR, Kobilka BK. Intracellular targetting and trafficking of thrombin receptors. J Biol Chem. 1994;269:27719-27726.
35. Böhm SK, Khitin LM, Grady EF, Aponte G, Payan DG, Bunnett NW. Mechanisms of desensitisation and resensitisation of proteinase-activated receptor-2. J Biol Chem. 1996;271:22003-22016.
36. Molino M, Barnathan ES, Numero R, Clark J, Dreyer M, Cumashi A, Hoxie JA, Schechter N, Woolkalis M, Brass LF. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem. 1997;272: 4043-4049.